A novel lead compound CM-118: antitumor activity and new insight into the molecular mechanism and combination therapy strategy in c-Met- and ALK-dependent cancers.
about
A novel lead compound CM-118: antitumor activity and new insight into the molecular mechanism and combination therapy strategy in c-Met- and ALK-dependent cancers.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
A novel lead compound CM-118: ...... et- and ALK-dependent cancers.
@en
A novel lead compound CM-118: ...... et- and ALK-dependent cancers.
@nl
type
label
A novel lead compound CM-118: ...... et- and ALK-dependent cancers.
@en
A novel lead compound CM-118: ...... et- and ALK-dependent cancers.
@nl
prefLabel
A novel lead compound CM-118: ...... et- and ALK-dependent cancers.
@en
A novel lead compound CM-118: ...... et- and ALK-dependent cancers.
@nl
P2093
P2860
P356
P1476
A novel lead compound CM-118: ...... et- and ALK-dependent cancers.
@en
P2093
Chris Liang
Dexiao Yang
Lanfang Meng
Mengjun Shu
Yaqing Chen
Zhiyong Feng
P2860
P304
P356
10.4161/CBT.28409
P577
2014-03-11T00:00:00Z